Corcept Therapeutics | CORT - Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Ardelyx USD 83.39M 1.67M 2025-09
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 124.12M 32.76M 2025-09
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 81.1M 17.56M 2025-09
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
J&J USD 54.13B 3.26B 2025-12
Knight Therapeutics CAD 152.68M 1.27M 2025-09
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 32B 286M 2025-09
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12